BRTX vs PH · rev $401.0K vs P/E 28, rev $19.85B
BioRestorative Therapies Inc (BRTX) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
BRTX currently screens at market cap $10.2M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the BRTX and PH stock pages for the full models.
Not investment advice.